 |
 |
 |
 |
 |
| |
![[Video] Immuno-Cell: Cytotoxicity towards Cancer Cell](../images/sideMenu_service_00mve.gif) |
|
Since Immuno-Cell Therapy is wholly custom-made treatment which practiced by autologus cells of each patient, qualities of each processed autologus immuno-cells are different. Therefore, the qualities of each processed autologus immuno-cells must be assured by safety and quality control at Cell Processing Center (“CPC,”) which equalizes certain degree of high quality and safety in cell processing
At present, there is no regulatory guideline for quality and safety control in cell-processing. Consequently, each medical institution voluntarily adopts own criteria for their facility and own standard for their quality control. Without having appropriate regulations, we have feared that there might be some medical institutions imprudently performing cell processing with no safety control and no quality assurance.
|
 |
 |
 |
In light of the issue in above, MEDINET has established certain criteria of facility and standard of quality control, which were based upon its most accumulated experience of cell-processing in the world.(See the Table below)
|
|
 |
Immuno-cells of patients can not be sterilized by heat or filtration, as sterilization of heat or filtration will also kill immuno-cells as well as bacteria. Therefore, it is necessary to avoid contamination of bacteria from air or immuno-cells of other patients in cell-processing as a safety control.
There are two main elements of safety controls as stated below;- |
(1) Facility and Equipments
Since immuno-cells of patients must be prevented from air contamination, the place, where immuno-cells are processed, must be closed facility. MEDINET controls cleanness of air within the CPC by followings;-
| 1. |
Clean filter check at regular intervals |
| 2. |
Inspection on cleanness of air in the CPC |
| 3. |
Other tests to ensure clean air |
| 4. |
Latest air-conditioning technology (Different air pressure among rooms and air stream direction ) |
|
(2) Safety Inspection
MEDINET forms a series of safety inspections into the Standard Operating Procedure (“SOP.”) Inspection Engineers will perform safety inspections from pre-processed immuno-cells to post-processed immuno-cells. These safety inspections include sterile test, test using a small amount of autologous plasma and other tests. |
Pathogenic virus is checked. |
 |
 |
In general, quality assurance of a product is performed over production and resources. MEDINET has established its original quality assurance management, which is based on concepts of Good Manufacturing Practice (“GMP”) and Bio Safety, over materials, inspections, and cell-processing. Our quality assurance management is mainly structured with three factors;- |
 |
(1) Materials
MEDINET select pharmaceuticals, medical devices or equivalent materials (e.g.; media, culture bags/flask and etc.) as materials used in cell-processing. The selection of materials is one of key factor to ensure quality and safety of processed immuno-cells.
The criteria of selected materials used in cell-processing are followed;-
| @ |
Pharmaceuticals or Medical Devices, approved under the Pharmaceutical Affair Law |
| A |
Specialized or Customized materials (e.g.: media, culture bags/flask and etc.,)
developed with major pharmaceutical manufacturer and media manufacturer |
| B |
Recommended or selected materials by medical doctors or other experts of material selection |
|
 |
(2) Quality Inspection
Quality inspection in cell-processing is that cell engineers generally inspect sterility and function of immuno-cells. To ensure fair evaluation of quality, MEDINET assigns inspection engineers at separated division from cell-processing division. This is only because quality inspection must be performed with view of objective evaluation of quality. Quality inspection is performed at each stage of cell-processing, and includes visual observation, sterile test, cell number test, viability test, endotoxin test, and etc.
|
 |
(3) Evaluation of Performance
The key factor for quality assurance management is to perform PDCA (Plan-Do-Check-Act) cycle over cell-processing. PDCA cycle refers establishment of the SOP for cell process and inspection, implementation of the SOP, evaluation of processed immuno-cells, and improvement of performance in our quality assurance management.
MEDINET has implemented such PDCA approach to ensure quality and safety of processed immuno-cells, and has also taken third party evaluation, such as ISO9001, on our quality assurance management. (See further information at “ISO9001 Qualified Service.”)
|
In cell therapy, quality of processed cells is generally depending on who perform cell-processing. In other word, cell-processing is manual-handing process, so that experience and skills of cell engineers directly influence quality of processed cells. To keep quality of processed cells, cell engineers must be trained, and will be able to perform appropriate process by cell condition.
MEDINET has established original training programs for cell engineer and inspection engineer, and has set certain criteria in the training program for our cell engineers and inspection engineers to learn at each stage. Cell engineers and inspection engineers, who are qualified as professionals in cell-processing and quality inspection through such training program, are allowed to engage in actual cell-processing and quality inspection under the supervision of physicians at Contracted Medical Institution. |
 |
| Automatic recognition system using bar code is being introduced to all the facilities.
|
 |
Ability of a cell engineer is examined. |
 |
One of the most emphasized points is to construct a systematic education for the cell engineer. |
MEDINET provides a computerized central system, which controls temperature, carbon dioxide concentration, and oxygen concentration for storing media and drugs in real time for 24 hours and 365 days. Such computerized central system will also send an e-mail notification to mobile phones of cell engineers when accident happens in clean rooms. |
|
MEDINET makes day-to-day efforts to ensure safety and quality of processed-cells so that the Contracted Medical Institutions can safely conduct immuno-cell therapy.
|
|
|
|